Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) International (3)
  • (-) Chroom-6 (1)
  • COVID-19 (4)
  • Chromium (VI) and CARC (1)
  • Medical devices (1)

Publication date

  • April 2020 (1)
  • February 2019 (3)

More reports of adverse effects of implants in 2019

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

28-04-2020 | 12:54

WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals

RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.

21-02-2019 | 13:21

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

18-02-2019 | 15:44
Treinloods chroom-6 tROM Tilburg

Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.

06-02-2019 | 14:24

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram